Advanced Oncotherapy making significant progress; in stronger position to assess funding options

Advanced Oncotherapy PLC saw its shares jump 10% as the firm said it remains on track to build a next-generation proton therapy system capable of treating superficial tumours by the end of the third-quarter next year, according to chief executive Nicolas Serandour.
Proactive Investors